Page last updated: 2024-11-06

n-isobutyrylglycine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

N-isobutyrylglycine: found in urine of patients with glyceric acidemia [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

N-isobutyrylglycine : An N-acylglycine in which the acyl group is specified as isobutryl. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10855600
CHEMBL ID2158191
CHEBI ID70979
SCHEMBL ID622544
MeSH IDM0087778

Synonyms (44)

Synonym
2-(2-methylpropanamido)acetic acid
EN300-31100
BB 0217128
(isobutyrylamino)aceticacid
n-isobutyrylglycine
n-(2-methylpropanoyl)glycine
AKOS000100039
2-(2-methylpropanoylamino)acetic acid
(isobutyrylamino)acetic acid
15926-18-8
2-(isobutyrylamino)acetic acid
CHEMBL2158191
FT-0670430
[(2-methylpropanoyl)amino]acetic acid
n-isobutanoylglycine
isobutanoylglycine
CHEBI:70979 ,
isobutyrylglycine
SCHEMBL622544
AB01332908-02
2-isobutyramidoacetic acid
DTXSID10445943
(isobutyrylamino)acetic acid, aldrichcpr
mfcd09043666
n-isobutyrylglycine (isobutyryl-gly-oh)
n-isobutyrylglycine, analytical reference material
AS-61842
isobutyrylamino acetic acid
F20066
J-009586
NCGC00340663-01
Q27139227
glycine, n-(2-methyl-1-oxopropyl)-
CS-0201719
iso-butyrylglycine
unii-4cwa98g3l7
4cwa98g3l7 ,
n-(2-methyl-1-oxopropyl)glycine
A856021
1219795-05-7
2-isobutyramidoaceticacid
HY-W141928
isobutyroyl glycine-2d2
Z85886685
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
human urinary metaboliteAny metabolite (endogenous or exogenous) found in human urine samples.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
N-acylglycineAn N-acyl-amino acid in which amino acid specified is glycine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Leucine, isoleucine and valine metabolism2470

Bioassays (2)

Assay IDTitleYearJournalArticle
AID695876Cytotoxicity against drug-resistant human KBV1 cells expressing P-gp incubated for 72 hrs by MTT assay2011Journal of medicinal chemistry, Jul-28, Volume: 54, Issue:14
Collateral sensitivity of multidrug-resistant cells to the orphan drug tiopronin.
AID695877Cytotoxicity against human KB-3-1 cells incubated for 72 hrs by MTT assay2011Journal of medicinal chemistry, Jul-28, Volume: 54, Issue:14
Collateral sensitivity of multidrug-resistant cells to the orphan drug tiopronin.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (40.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (40.00%)4.05%
Observational0 (0.00%)0.25%
Other3 (60.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]